Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

B. Fisher, Carol Redmond, R Poisson et al. · New England Journal of Medicine · 1989 · 1.5K citations

Medicine, Oncology, Pharmacotherapy +13

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.

Yolande Berthois, John A. Katzenellenbogen, Benita S. Katzenellenbogen · Proceedings of the National Academy of Sciences · 1986 · 1.3K citations · Full text

Life Sciences, Biochemistry, Endocrinology +13

Adjuvant tamoxifen in the management of operable breast cancer : Scottish Trial

Scottish Cancer Trials Office · The Lancet · 1987 · 429 citations

Medicine, Oncology, Breast Oncology +10

Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment.

Ernst A. Lien, Einar Solheim, Oscar A. Lea et al. · PubMed · 1989 · 234 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme

Trevor J. Powles, C R Tillyer, Alison L. Jones et al. · European Journal of Cancer and Clinical Oncology · 1990 · 160 citations

Medicine, Gynecology, Oncology +14